H.R. 467HALT Fentanyl Act

2 recorded actions296 of these members are on the 2026 ballotWhat the measure does Read on Congress.gov

Sponsor: H. Morgan Griffith [R-VA-09]
Cosponsors: 52 · 52 Republicans
Policy area: Crime and Law Enforcement
Committees: Energy and Commerce Committee, Judiciary Committee
Latest action: May 30, 2023 · Received in the Senate and Read twice and referred to the Committee on the Judiciary.

IntroducedJan 24, 2023
Passed the HouseMay 25, 2023
Passed the SenateNot yet reached
Sent to the PresidentNot yet reached
Became lawNot yet reached

What the measure doesCRS summary

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

(The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.)

Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

permitting a single registration for related research sites in certain circumstances,
waiving the requirement for a new inspection in certain situations, and
allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Written by the nonpartisan Congressional Research Service, describing H.R. 467 as passed House on May 25, 2023. It is not the text of the measure; a later amendment may have changed what it does.

Roll calls on H.R. 4672 roll calls on this measure

Choose a roll call

May 25, 2023Each bar: ✓ Yea from the bottom, ✕ Nay aboveMay 25, 2023

How every member votedHouse roll call 237

House May 25, 2023 · the primary vote

On Passage

HALT Fentanyl Act

Passed

289 Yea 133 Nay 13 not voting

Crossed both parties 75 of 422 voting members broke with their own party: 74 Democrats, 1 Republican.

Open the official roll call

How the chamber split

One dot per member. Select a seat or a bar to filter the list.

DemocratsRepublicansFilled: YeaRing: NayGrey: not voting or present

By party select a segment to filter

All members435 members

Democratic213 members

Republican222 members

marks half of the votes cast. A party’s majority is the side most of its voting members took.

Cosponsors52 · 52 Republicans

Signing on is not a vote: a member can cosponsor H.R. 467 and vote against it. 24 signed when it was filed.

Loading the public record

Who lobbied on H.R. 46716 organizations

Organizations that named H.R. 467 in a lobbying disclosure. Only those that cited the bill by number appear, so this is a floor, not a full list.

FAMILIES AGAINST MANDATORY MINIMUMS

Law Enforcement/Crime/Criminal Justice9 filings · 4th Quarter (Oct 1 - Dec 31) 2024Filing

DUE PROCESS INSTITUTE

Civil Rights/Civil Liberties · Constitution · Law Enforcement/Crime/Criminal Justice · Intelligence +4 more8 filings · 4th Quarter (Oct 1 - Dec 31) 2024Filing

THE SENTENCING PROJECT

Law Enforcement/Crime/Criminal Justice8 filings · 4th Quarter (Oct 1 - Dec 31) 2024Filing

PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIAfiled by STEPTOE LLP

Law Enforcement/Crime/Criminal Justice6 filings · 4th Quarter (Oct 1 - Dec 31) 2024Filing

NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)

Law Enforcement/Crime/Criminal Justice5 filings · 4th Quarter (Oct 1 - Dec 31) 2024Filing

AMERICAN SOCIETY OF ANESTHESIOLOGISTSIts PAC: American Society of Anesthesiologists PAC

Medicare/Medicaid · Health Issues · Veterans4 filings · 1st Quarter (Jan 1 - Mar 31) 2024Filing

LEADERSHIP CONFERENCE ON CIVIL AND HUMAN RIGHTS

Education · Government Issues · Telecommunications · Labor Issues/Antitrust/Workplace +12 more4 filings · 1st Quarter (Jan 1 - Mar 31) 2024Filing

AMERICAN MEDICAL ASSOCIATIONIts PAC: American Medical Association PAC

Labor Issues/Antitrust/Workplace · Medicare/Medicaid · Taxation/Internal Revenue Code · Torts +6 more3 filings · 4th Quarter (Oct 1 - Dec 31) 2023Filing

HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)filed by HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)Its PAC: Healthcare Distribution Alliance PAC

Pharmacy · Health Issues2 filings · 2nd Quarter (Apr 1 - June 30) 2023Filing

HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)filed by TARPLIN, DOWNS & YOUNG, LLC

Pharmacy · Health Issues2 filings · 2nd Quarter (Apr 1 - June 30) 2023Filing

58 disclosures name this measure. Retrieved from LDA.gov on 2026-10-04. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.